These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36139239)

  • 1. What Happens in Male Dogs after Treatment with a 4.7 mg Deslorelin Implant? I. Flare up and Downregulation.
    Stempel S; Körber H; Reifarth L; Schuler G; Goericke-Pesch S
    Animals (Basel); 2022 Sep; 12(18):. PubMed ID: 36139239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Happens in Male Dogs after Treatment with a 4.7 mg Deslorelin Implant? II. Recovery of Testicular Function after Implant Removal.
    Stempel S; Körber H; Reifarth L; Schuler G; Goericke-Pesch S
    Animals (Basel); 2022 Sep; 12(19):. PubMed ID: 36230286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a 4.7 mg deslorelin slow release implant in male dogs in the field.
    Vasetska A; Körber H; Pilgram C; Schuler G; Aslan S; Saral G; Binli F; Akal E; Selcuk M; Ay S; Findik M; Fontaine CS; Goericke-Pesch S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Aug; 51(4):231-241. PubMed ID: 37820614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of implants containing the GnRH agonist deslorelin on testosterone release and semen characteristics in Shetland stallions.
    Gautier C; Schmidt K; Aurich J; Aurich C
    Anim Reprod Sci; 2018 Aug; 195():230-241. PubMed ID: 29859702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant "Gonazon"; a preclinical trial.
    Ludwig C; Desmoulins PO; Driancourt MA; Goericke-Pesch S; Hoffmann B
    Theriogenology; 2009 Apr; 71(7):1037-45. PubMed ID: 19233456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog.
    Balogh O; Somoskői B; Kollár E; Kowalewski MP; Gram A; Reichler IM; Klein R; Kawate N; Mester L; Walter B; Müller L
    Theriogenology; 2021 Nov; 175():100-110. PubMed ID: 34534687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of semen quality following reversible downregulation of testicular function in male dogs with a GnRH agonist implant.
    Goericke-Pesch S; Ludwig C; Hoffmann B
    Reprod Domest Anim; 2012 Aug; 47(4):625-8. PubMed ID: 22050326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular Expression of Antioxidant Enzymes and Changes in Response to a Slow-Release Deslorelin Implant (Suprelorin
    Gram DY; Sexton B; Liman N; Müller L; Abay M; Gram A; Balogh O
    Animals (Basel); 2022 Sep; 12(18):. PubMed ID: 36139204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants.
    Junaidi A; Williamson PE; Martin GB; Stanton PG; Blackberry MA; Cummins JM; Trigg TE
    Reprod Fertil Dev; 2007; 19(8):891-8. PubMed ID: 18076821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs.
    Junaidi A; Williamson PE; Cummins JM; Martin GB; Blackberry MA; Trigg TE
    Reprod Fertil Dev; 2003; 15(6):317-22. PubMed ID: 14975229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term release GnRH agonist "deslorelin" on testicular HSP expression, accessory sex glands and testicular functions in adult male rats.
    Eşki F; Çetin N; Uslu S; Uslu BA; Şendağ S; Yörük M; Naseer Z; Wehrend A; Shakeel M
    Theriogenology; 2019 Aug; 134():104-111. PubMed ID: 31158733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal testosterone concentrations after the application of a slow-release GnRH agonist implant are associated with a loss of response to buserelin, a short-term GnRH agonist, in the tom cat.
    Goericke-Pesch S; Georgiev P; Fasulkov I; Vodenicharov A; Wehrend A
    Theriogenology; 2013 Jul; 80(1):65-9. PubMed ID: 23622940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible estrous cycle suppression in prepubertal female rabbits treated with slow-release deslorelin implants.
    Geyer A; Daub L; Otzdorff C; Reese S; Braun J; Walter B
    Theriogenology; 2016 Jan; 85(2):282-7. PubMed ID: 26489909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological study of the effects of the GnRH superagonist deslorelin on the canine testis and prostate gland.
    Junaidi A; Williamson PE; Trigg TE; Cummins JM; Martin GB
    Reprod Domest Anim; 2009 Oct; 44(5):757-63. PubMed ID: 21815286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of contraception in some African wild carnivores by downregulation of LH and FSH secretion using the GnRH analogue deslorelin.
    Bertschinger HJ; Trigg TE; Jöchle W; Human A
    Reprod Suppl; 2002; 60():41-52. PubMed ID: 12220163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-Blind, Placebo-Controlled Trial of Cyproterone Acetate to Prevent Flare-Up Effect on Dogs Implanted With Deslorelin.
    Masson S; Medam T; Raibon E; Fontaine C; Levy X
    Front Vet Sci; 2021; 8():714154. PubMed ID: 34660758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semen quality and onset of sterility following administration of a 4.7-mg deslorelin implant in adult male dogs.
    Romagnoli S; Siminica A; Sontas BH; Milani C; Mollo A; Stelletta C
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():389-92. PubMed ID: 23279546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of germinative and endocrine testicular function after long-term contraception with a GnRH-agonist implant in the tom-a follow-up study.
    Goericke-Pesch S; Georgiev P; Antonov A; Vodenicharov A; Navarro C; Wehrend A
    Theriogenology; 2014 Apr; 81(7):941-6. PubMed ID: 24581586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azoospermia with variable testicular histology after 7 months of treatment with a deslorelin implant in toms.
    Novotny R; Vitasek R; Bartoskova A; Cizek P; Prinosilova P; Novakova K
    Theriogenology; 2015 Apr; 83(7):1188-93. PubMed ID: 25617987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GnRH agonist implants in small animal practice - what do we know 13 years following EU registration?].
    Stempel S; Goericke-Pesch S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Dec; 48(6):420-432. PubMed ID: 33276392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.